SEC Form 4 · accession 0001209191-15-011462

HeartWare International, Inc. · HTWR

Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗

Reporting owner

Officer — President & Chief Exec Officer · Director

Period of report

Feb 7, 2015

Accepted (ET)

Feb 10, 2015 · 5:02 pm EST

Rule 10b5-1 plan

unknown — predates the checkbox

Issuer CIK

0001389072

Table I — non-derivative securities

Security	Date	Code	Shares	Price	A/D	Owned after	D/I
Common Stock^F1	Feb 7, 2015	M	5,000	$0.00	A	68,710	D
Common Stock^F2,F3	Feb 9, 2015	S	1,598	$86.52	D	67,112	D
Common Stock	Feb 9, 2015	S	100	$87.55	D	67,012	D

Security	Conv. / exercise price	Date	Code	Shares	A/D	Exercisable	Expires	Underlying	Underlying shares	Owned after	D/I
Restricted Stock Unit^F4	—	Feb 7, 2015	M	5,000	D	Feb 7, 2015	Feb 7, 2015	Common Stock	5,000	41,000	D

F1On May 21, 2013, upon receipt of stockholder approval, the reporting person was granted restricted stock units to acquire 20,000 shares of HeartWare International common stock. The award vests in four installments on February 7, 2014, February 7, 2015, February 7, 2016 and February 7, 2017. On February 7, 2015, 5,000 shares of common stock were issued to the reporting person.
F2These shares were sold pursuant to a pre-arranged trading plan in accordance with Rule 10b5-1 of the Securities Exchange Act of 1934. The sale proceeds were utilized to pay all payroll taxes related to the vesting of restricted stock units and receipt of the related shares reported on this Form 4.
F3The price represents the weighted average sale price for multiple transactions reported on this line. The prices of the transactions ranged from $86.05 to $86.95. The reporting person has provided the issuer and will provide any security holder of the issuer or the SEC Staff, upon request, information regarding the number of shares sold at each price within the range.
F4Each restricted stock unit represents a contingent right to receive one share of the Company's common stock.